Zoetis Inc. acquired Ethos Diagnostic Science, a veterinary reference lab company dedicated to providing accurate and reliable results to leading veterinary hospitals, the entire veterinary community, and researchers. Zoetis continued to expand the number of diagnostic tests available, with a view to making them wide and more useful for veterinarians in the U.S., following its entry into the field of veterinary reference laboratories through the acquisitions of both Phoenix Lab and ZNLabs in 2019.
LE SNAPISH 4x was launched by IDEXX Laboratories Inc., a global leader in animal health innovations and one of the first to launch an entire vectorborne disease screening test that included canine leishmaniosis.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 3938
Published Date: Jan 23, 2024
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
The growing integration of strategies by market players and demand for animal-derived food products are some of the major factors anticipated to drive the growth of the veterinary rapid test market.
The market is anticipated to attain a CAGR of ~8.02% over the forecast period, i.e., 2024-2036.
The major players in the market are of Fassisi GmbH, Bionote USA Inc., Swissavans AG., MEGACOR Veterinary Diagnostics, Woodley Equipment Company Ltd., and others.
The rapid test kit segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in Asia Pacific is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.